File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Deep‐Learning‐Based MRI Microbleeds Detection for Cerebral Small Vessel Disease on Quantitative Susceptibility Mapping

TitleDeep‐Learning‐Based MRI Microbleeds Detection for Cerebral Small Vessel Disease on Quantitative Susceptibility Mapping
Authors
Keywordscerebral microbleeds
CycleGAN
deep learning
quantitative susceptibility mapping
ResNet
V-Net
Issue Date27-Dec-2023
PublisherWiley
Citation
Journal of Magnetic Resonance Imaging, 2023 How to Cite?
Abstract

Background

Cerebral microbleeds (CMB) are indicators of severe cerebral small vessel disease (CSVD) that can be identified through hemosiderin-sensitive sequences in MRI. Specifically, quantitative susceptibility mapping (QSM) and deep learning were applied to detect CMBs in MRI.

Purpose

To automatically detect CMB on QSM, we proposed a two-stage deep learning pipeline.

Study Type

Retrospective.

Subjects

A total number of 1843 CMBs from 393 patients (69 ± 12) with cerebral small vessel disease were included in this study. Seventy-eight subjects (70 ± 13) were used as external testing.

Field Strength/Sequence

3 T/QSM.

Assessment

The proposed pipeline consisted of two stages. In stage I, 2.5D fast radial symmetry transform (FRST) algorithm along with a one-layer convolutional network was used to identify CMB candidate regions in QSM images. In stage II, the V-Net was utilized to reduce false positives. The V-Net was trained using CMB and non CMB labels, which allowed for high-level feature extraction and differentiation between CMBs and CMB mimics like vessels. The location of CMB was assessed according to the microbleeds anatomical rating scale (MARS) system.

Statistical Tests

The sensitivity and positive predicative value (PPV) were reported to evaluate the performance of the model. The number of false positive per subject was presented.

Results

Our pipeline demonstrated high sensitivities of up to 94.9% at stage I and 93.5% at stage II. The overall sensitivity was 88.9%, and the false positive rate per subject was 2.87. With respect to MARS, sensitivities of above 85% were observed for nine different brain regions.

Data Conclusion

We have presented a deep learning pipeline for detecting CMB in the CSVD cohort, along with a semi-automated MARS scoring system using the proposed method. Our results demonstrated the successful application of deep learning for CMB detection on QSM and outperformed previous handcrafted methods.


Persistent Identifierhttp://hdl.handle.net/10722/339884
ISSN
2023 Impact Factor: 3.3
2023 SCImago Journal Rankings: 1.339
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorXia, Peng-
dc.contributor.authorHui, Edward S-
dc.contributor.authorChua, Bryan J-
dc.contributor.authorHuang, Fan-
dc.contributor.authorWang, Zuojun-
dc.contributor.authorZhang, Huiqin-
dc.contributor.authorYu, Han-
dc.contributor.authorLau, Kui Kai-
dc.contributor.authorMak, Henry KF-
dc.contributor.authorCao, Peng-
dc.date.accessioned2024-03-11T10:40:01Z-
dc.date.available2024-03-11T10:40:01Z-
dc.date.issued2023-12-27-
dc.identifier.citationJournal of Magnetic Resonance Imaging, 2023-
dc.identifier.issn1053-1807-
dc.identifier.urihttp://hdl.handle.net/10722/339884-
dc.description.abstract<h3>Background</h3><p>Cerebral microbleeds (CMB) are indicators of severe cerebral small vessel disease (CSVD) that can be identified through hemosiderin-sensitive sequences in MRI. Specifically, quantitative susceptibility mapping (QSM) and deep learning were applied to detect CMBs in MRI.</p><h3>Purpose</h3><p>To automatically detect CMB on QSM, we proposed a two-stage deep learning pipeline.</p><h3>Study Type</h3><p>Retrospective.</p><h3>Subjects</h3><p>A total number of 1843 CMBs from 393 patients (69 ± 12) with cerebral small vessel disease were included in this study. Seventy-eight subjects (70 ± 13) were used as external testing.</p><h3>Field Strength/Sequence</h3><p>3 T/QSM.</p><h3>Assessment</h3><p>The proposed pipeline consisted of two stages. In stage I, 2.5D fast radial symmetry transform (FRST) algorithm along with a one-layer convolutional network was used to identify CMB candidate regions in QSM images. In stage II, the V-Net was utilized to reduce false positives. The V-Net was trained using CMB and non CMB labels, which allowed for high-level feature extraction and differentiation between CMBs and CMB mimics like vessels. The location of CMB was assessed according to the microbleeds anatomical rating scale (MARS) system.</p><h3>Statistical Tests</h3><p>The sensitivity and positive predicative value (PPV) were reported to evaluate the performance of the model. The number of false positive per subject was presented.</p><h3>Results</h3><p>Our pipeline demonstrated high sensitivities of up to 94.9% at stage I and 93.5% at stage II. The overall sensitivity was 88.9%, and the false positive rate per subject was 2.87. With respect to MARS, sensitivities of above 85% were observed for nine different brain regions.</p><h3>Data Conclusion</h3><p>We have presented a deep learning pipeline for detecting CMB in the CSVD cohort, along with a semi-automated MARS scoring system using the proposed method. Our results demonstrated the successful application of deep learning for CMB detection on QSM and outperformed previous handcrafted methods.<br></p>-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofJournal of Magnetic Resonance Imaging-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectcerebral microbleeds-
dc.subjectCycleGAN-
dc.subjectdeep learning-
dc.subjectquantitative susceptibility mapping-
dc.subjectResNet-
dc.subjectV-Net-
dc.titleDeep‐Learning‐Based MRI Microbleeds Detection for Cerebral Small Vessel Disease on Quantitative Susceptibility Mapping-
dc.typeArticle-
dc.identifier.doi10.1002/jmri.29198-
dc.identifier.scopuseid_2-s2.0-85180870049-
dc.identifier.eissn1522-2586-
dc.identifier.isiWOS:001132742000001-
dc.identifier.issnl1053-1807-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats